TY - JOUR
T1 - Corrigendum to ‘Comparison of Outcomes of Transfemoral Aortic Valve Implantation in Patients <90 to Those >90 Years of Age [American Journal of Cardiology (2018) 1581–1586](***–***)(10.1016/j.amjcard.2018.02.056)
AU - Vendrik, Jeroen
AU - van Mourik, Martijn S.
AU - van Kesteren, Floortje
AU - Henstra, Marieke J.
AU - Piek, Jan J.
AU - Henriques, Jose P. S.
AU - Wykrzykowska, Joanna J.
AU - de Winter, Robbert J.
AU - Marije Vis, M.
AU - Koch, Karel T.
AU - Baan, Jan
PY - 2018
Y1 - 2018
N2 - The authors regret that Table 1 was incorrect. Regarding the baseline table (Table 1); most of the baseline differences between the groups are incorrect (% men, previous stroke, eGFR <60ml/min/1,73m2, presence of moderate to severe MR), but some statistically significant differences are not reported in the original publication (lower BMI, smaller AVA and significantly higher EuroSCORE-II in the >90 year old). In our opinion, these changes leading to less differences between the groups, makes the groups (i.e. >90 and <90 years) more comparable and thus this strengthens our finding that the higher predicted postoperative mortality scores in the oldest patients are most likely predominantly influenced by their advanced age. Furthermore, regarding the outcome table (Table 2), significant differences (valve types used, amount of AR and % device success, as well as post-procedural stroke and major vascular complications) are not statistically significant, as opposed to the p-values we reported. This, in our opinion, equals the outcomes of the oldest patients and the rest of the cohort, strengthening our conclusion that whether or not to perform TAVI should not be based on age, based on the very similar outcomes in both groups. The authors would like to apologise for any inconvenience caused.
AB - The authors regret that Table 1 was incorrect. Regarding the baseline table (Table 1); most of the baseline differences between the groups are incorrect (% men, previous stroke, eGFR <60ml/min/1,73m2, presence of moderate to severe MR), but some statistically significant differences are not reported in the original publication (lower BMI, smaller AVA and significantly higher EuroSCORE-II in the >90 year old). In our opinion, these changes leading to less differences between the groups, makes the groups (i.e. >90 and <90 years) more comparable and thus this strengthens our finding that the higher predicted postoperative mortality scores in the oldest patients are most likely predominantly influenced by their advanced age. Furthermore, regarding the outcome table (Table 2), significant differences (valve types used, amount of AR and % device success, as well as post-procedural stroke and major vascular complications) are not statistically significant, as opposed to the p-values we reported. This, in our opinion, equals the outcomes of the oldest patients and the rest of the cohort, strengthening our conclusion that whether or not to perform TAVI should not be based on age, based on the very similar outcomes in both groups. The authors would like to apologise for any inconvenience caused.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85050963374&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30093069
U2 - https://doi.org/10.1016/j.amjcard.2018.07.010
DO - https://doi.org/10.1016/j.amjcard.2018.07.010
M3 - Article
C2 - 30093069
SN - 0002-9149
VL - 122
SP - 2173
EP - 2175
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 12
ER -